New blood test could replace risky prenatal procedures for genetic diseases
NCT ID NCT07469657
First seen Mar 16, 2026 · Last updated May 07, 2026 · Updated 8 times
Summary
This study looks at whether a new, non-invasive blood test using next-generation sequencing can replace current methods for diagnosing severe genetic diseases in unborn babies. The test analyzes fetal DNA from the mother's blood, avoiding the need for invasive procedures like amniocentesis. Researchers will compare the costs and benefits of this new approach in 300 couples at risk of passing on a serious genetic condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC DISEASES, INBORN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Necker Enfants Malades
Paris, Île-de-France Region, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.